P. Jeffrey Conn left a full professorship for a job in Big Pharma 11 years ago because he saw no path in academe to turn his novel idea for treating Parkinson's disease into an actual drug. Now he and a corps of scientists are closing in on a molecule that could bring relief to the millions suffering with the condition's debilitating tremors and paralysis.
To read the full, original article click on this link: Big Pharma Finds a Home on Campus - Administration - The Chronicle of Higher Education
Author: Goldie Blumenstyk
